Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ARNA | IBRX | APLS | ||
Company | Arena Pharmaceuticals | Immunitybio Inc | Apellis Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 99.97 | 9.48 | 48.46 | ||
High | 100.00 | 10.01 | 48.76 | ||
Low | 99.97 | 8.65 | 47.22 | ||
Last | 99.99 | 9.15 | 47.46 | ||
Change | +0.06 | +0.18 | -0.03 | ||
% Change | +0.06% | +2.01% | -0.06% | ||
Volume | 5,718,500 | 14,704,199 | 1,106,900 | ||
20-Day Average Volume | 1,676,465 | 12,606,000 | 1,600,485 | ||
Previous Close | 99.93 | 8.97 | 47.49 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 94.81 | 6.32 | 49.84 | ||
20-Day Raw Stochastic | 99.86% | 76.21% | 47.07% | ||
20-Day Relative Strength | 75.07% | 66.96% | 40.14% | ||
Weighted Alpha | -14.40 | +16.67 | -20.24 | ||
Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
Previous Opinion | 100% Buy | 100% Buy | 56% Sell | ||
Last Month's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +6.34% since 03/03/22 | +24.49% since 04/26/24 | -4.81% since 04/26/24 | ||
Low | 93.54 on 03/07/22 | 7.45 on 05/01/24 | 38.22 on 04/30/24 | ||
High | 100.00 on 03/10/22 | 10.53 on 04/29/24 | 49.38 on 04/29/24 | ||
1-Month | |||||
%Chg | +6.37% since 02/10/22 | +60.25% since 04/03/24 | -16.66% since 04/03/24 | ||
Low | 92.85 on 02/22/22 | 4.73 on 04/12/24 | 38.22 on 04/30/24 | ||
High | 100.00 on 03/10/22 | 10.53 on 04/29/24 | 58.12 on 04/04/24 | ||
3-Month | |||||
%Chg | +100.22% since 12/10/21 | +121.01% since 02/02/24 | -24.14% since 02/02/24 | ||
Low | 89.03 on 01/25/22 | 3.37 on 02/23/24 | 38.22 on 04/30/24 | ||
High | 100.00 on 03/10/22 | 10.53 on 04/29/24 | 71.90 on 02/26/24 | ||
6-Month | |||||
%Chg | +68.36% since 09/10/21 | +144.00% since 11/03/23 | +1.35% since 11/03/23 | ||
Low | 48.12 on 12/06/21 | 2.66 on 11/10/23 | 38.22 on 04/30/24 | ||
High | 100.00 on 03/10/22 | 10.53 on 04/29/24 | 73.80 on 01/09/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,165,283 | 6,194,577 | 5,756,613 | ||
Shares Outstanding, K | 61,659 | 677,003 | 121,294 | ||
Annual Sales | 50,000 | 620,000 | 396,590,000 | ||
Annual Net Income | -616,430,000 | -583,200,000 | -528,630,000 | ||
Last Quarter Sales | 50,000 | 140,000 | 146,380,000 | ||
Last Quarter Net Income | -155,610,000 | -233,390,000 | -88,580,000 | ||
60-Month Beta | 0.55 | 1.16 | 0.97 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.54 on 02/23/22 | -0.19 on 03/19/24 | -0.73 on 02/27/24 | ||
Latest Earnings Date | 05/04/22 | 05/09/24 | 05/07/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |